ZYVERSA THERAPEUTICS, INC. Deposits Assets, Current
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Deposits Assets, Current of $14.48 thousand as of 2025-12-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DepositsAssetsCurrent · last filed 2026-05-13
- 2025-12-31: Deposits Assets, Current $14.48K.
- 2025-09-30: Deposits Assets, Current $169.36K.
- 2025-06-30: Deposits Assets, Current $98.23K.
| Period end | Deposits Assets, Current |
|---|---|
| 2025-12-31 | $14.48K 10-Q · filed 2026-05-13 |
| 2025-09-30 | $169.36K 10-Q · filed 2025-11-19 |
| 2025-06-30 | $98.23K 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |